Human fatalities from cyanobacteria: chemical and biological evidence for cyanotoxins.

Carmichael WW, Azevedo SM, An JS, Molica RJ, Jochimsen EM, Lau S, Rinehart KL, Shaw GR, Eaglesham GK. · 2001

Read Human fatalities from cyanobacteria: chemical and biological evidence for cyanotoxins. by Carmichael WW, Azevedo SM, An JS, Molica RJ, Jochimsen EM, Lau S, Rinehart KL, Shaw GR, Eaglesham GK. (2001) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1240368.txt.

Introduction

Carmichael and a large team investigated deadly poisonings in Brazil in 2001. At a dialysis clinic in Caruaru, patients fell ill after treatment. Most showed vision problems, nausea, and vomiting. One hundred developed acute liver failure, and 76 died.

Water source checks found algae that make potent toxins. Patient blood and liver samples held the same toxin groups. Two toxin types from cyanobacteria were identified. Animal study comparisons pointed to one group as the main killer. Carmichael shows how tainted water reached patients through dialysis lines. Fifty-two deaths were tied to the named syndrome by December 1996.

Catalog record

CREATORCarmichael WW, Azevedo SM, An JS, Molica RJ, Jochimsen EM, Lau S, Rinehart KL, Shaw GR, Eaglesham GK.
YEAR2001
COLLECTIONPAPERS
FORMATTXT
FILE SIZE6 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1240368

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Human fatalities from cyanobacteria: chemical and biological evidence for cyanotoxins.

By W W Carmichael, S M Azevedo, J S An, R J Molica, E M Jochimsen, S Lau, K L Rinehart, G R Shaw, G K Eaglesham

Published in: Environmental Health Perspectives

DOI: 10.1289/ehp.01109663

ABSTRACT

Abstract

An outbreak of acute liver failure occurred at a dialysis center in Caruaru, Brazil (8 degrees 17' S, 35 degrees 58' W), 134 km from Recife, the state capital of Pernambuco. At the clinic, 116 (89%) of 131 patients experienced visual disturbances, nausea, and vomiting after routine hemodialysis treatment on 13-20 February 1996. Subsequently, 100 patients developed acute liver failure, and of these 76 died. As of December 1996, 52 of the deaths could be attributed to a common syndrome now called Caruaru syndrome. Examination of phytoplankton from the dialysis clinic's water source, analyses of the clinic's water treatment system, plus serum and liver tissue of clinic patients led to the identification of two groups of cyanobacterial toxins, the hepatotoxic cyclic peptide microcystins and the hepatotoxic alkaloid cylindrospermopsin. Comparison of victims' symptoms and pathology using animal studies of these two cyanotoxins leads us to conclude that the major contributing factor to death of the dialyses patients was intravenous exposure to microcystins, specifically microcystin-YR, -LR, and -AR. From liver concentrations and exposure volumes, it was estimated that 19.5 microg/L microcystin was in the water used for dialysis treatments. This is 19.5 times the level set as a guideline for safe drinking water supplies by the World Health Organization.

FULL TEXT

The Full Text of this article is available as a PDF (92.6 KB).

SELECTED REFERENCES

These references are in PubMed. This may not be the complete list of references from this article.
An J., Carmichael W. W. Use of a colorimetric protein phosphatase inhibition assay and enzyme linked immunosorbent assay for the study of microcystins and nodularins. Toxicon. 1994 Dec;32(12):1495–1507. doi: 10.1016/0041-0101(94)90308-5.Chu F. S., Huang X., Wei R. D. Enzyme-linked immunosorbent assay for microcystins in blue-green algal blooms. J Assoc Off Anal Chem. 1990 May-Jun;73(3):451–456.Dabholkar A. S., Carmichael W. W. Ultrastructural changes in the mouse liver induced by hepatotoxin from the freshwater cyanobacterium Microcystis aeruginosa strain 7820. Toxicon. 1987;25(3):285–292. doi: 10.1016/0041-0101(87)90257-1.Hillenkamp F., Karas M., Beavis R. C., Chait B. T. Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers. Anal Chem. 1991 Dec 15;63(24):1193A–1203A. doi: 10.1021/ac00024a002.Hirooka E. Y., Pinotti M. H., Tsutsumi T., Yoshida F., Ueno Y. Survey of microcystins in water between 1995 and 1996 in Paraná, Brazil using ELISA. Nat Toxins. 1999;7(3):103–109. doi: 10.1002/(sici)1522-7189(199905/06)7:3<103::aid-nt47>3.0.co;2-d.Ismail N., Becker B. N., Hakim R. M. Water treatment for hemodialysis. Am J Nephrol. 1996;16(1):60–72. doi: 10.1159/000168972.Jochimsen E. M., Carmichael W. W., An J. S., Cardo D. M., Cookson S. T., Holmes C. E., Antunes M. B., de Melo Filho D. A., Lyra T. M., Barreto V. S. Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil. N Engl J Med. 1998 Mar 26;338(13):873–878. doi: 10.1056/NEJM199803263381304.MacKintosh C., Beattie K. A., Klumpp S., Cohen P., Codd G. A. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett. 1990 May 21;264(2):187–192. doi: 10.1016/0014-5793(90)80245-e.Matsushima R., Yoshizawa S., Watanabe M. F., Harada K., Furusawa M., Carmichael W. W., Fujiki H. In vitro and in vivo effects of protein phosphatase inhibitors, microcystins and nodularin, on mouse skin and fibroblasts. Biochem Biophys Res Commun. 1990 Sep 14;171(2):867–874. doi: 10.1016/0006-291x(90)91226-i.Nishiwaki-Matsushima R., Ohta T., Nishiwaki S., Suganuma M., Kohyama K., Ishikawa T., Carmichael W. W., Fujiki H. Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J Cancer Res Clin Oncol. 1992;118(6):420–424. doi: 10.1007/BF01629424.Pouria S., de Andrade A., Barbosa J., Cavalcanti R. L., Barreto V. T., Ward C. J., Preiser W., Poon G. K., Neild G. H., Codd G. A. Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil. Lancet. 1998 Jul 4;352(9121):21–26. doi: 10.1016/s0140-6736(97)12285-1.Press F. Science and technology in the white house, 1977 to 1980: part 2. Science. 1981 Jan 16;211(4479):249–256. doi: 10.1126/science.211.4479.249.Robinson N. A., Miura G. A., Matson C. F., Dinterman R. E., Pace J. G. Characterization of chemically tritiated microcystin-LR and its distribution in mice. Toxicon. 1989;27(9):1035–1042. doi: 10.1016/0041-0101(89)90154-2.Robinson N. A., Pace J. G., Matson C. F., Miura G. A., Lawrence W. B. Tissue distribution, excretion and hepatic biotransformation of microcystin-LR in mice. J Pharmacol Exp Ther. 1991 Jan;256(1):176–182.Runnegar M. T., Andrews J., Gerdes R. G., Falconer I. R. Injury to hepatocytes induced by a peptide toxin from the cyanobacterium Microcystis aeruginosa. Toxicon. 1987;25(11):1235–1239. doi: 10.1016/0041-0101(87)90142-5.Runnegar M. T., Falconer I. R. Effect of toxin from the cyanobacterium Microcystis aeruginosa on ultrastructural morphology and actin polymerization in isolated hepatocytes. Toxicon. 1986;24(2):109–115. doi: 10.1016/0041-0101(86)90112-1.Theiss W. C., Carmichael W. W., Wyman J., Bruner R. Blood pressure and hepatocellular effects of the cyclic heptapeptide toxin produced by the freshwater cyanobacterium (blue-green alga) Microcystis aeruginosa strain PCC-7820. Toxicon. 1988;26(7):603–613. doi: 10.1016/0041-0101(88)90243-7.Williams D. E., Craig M., Dawe S. C., Kent M. L., Andersen R. J., Holmes C. F. 14C-labeled microcystin-LR administered to Atlantic salmon via intraperitoneal injection provides in vivo evidence for covalent binding of microcystin-LR in salmon livers. Toxicon. 1997 Jun;35(6):985–989. doi: 10.1016/s0041-0101(96)00196-1.

Read the complete text